Bio-Adrenomedullin as a Potential Quick, Reliable, and Objective Marker of Congestion in Heart Failure
Key result
Bio-ADM represents a potential marker of congestion in heart failure across LVEF tertiles.
- n=757
Why the study?
Is Bio-Adrenomedullin a reliable and objective marker of congestion in heart failure?
Population
Heart failure patients (n=757, based on tertile counts of 262, 241, and 254)
Design
Cohort
Authors
Discussion
Loading...
Member takes
Implication
Bio-ADM may aid objective congestion assessment in HF; leaves open its reliability as a routine marker pending validation.
Study Design
Type
Observational (n=757)
Structured PICO
Is Bio-Adrenomedullin a reliable and objective marker of congestion in heart failure?
P
Population
Heart failure patients (n=757, based on tertile counts of 262, 241, and 254)
E
Exposure
Bio-Adrenomedullin (Bio-ADM) measurement
O
Outcome
Congestionsurrogate
Bio-adrenomedullin is being evaluated as a potential quick, reliable, and objective marker of congestion in patients with heart failure.
Cite This Study
Kremer et al. (2018) conducted an observational in Heart failure (n=757). Biologically active adrenomedullin (Bio-ADM) was evaluated. Biologically active adrenomedullin (Bio-ADM) was evaluated as a potential marker of congestion in heart failure, with LVEF measured in 757 patients across three tertiles.